China Resources Pharmaceutical (03320.HK) subsidiary completes issuance of RMB900 million corporate bonds

Zhitong Finance APP News, China Resources Pharmaceutical (03320.HK) has announced that its wholly-owned subsidiary, China Resources Pharmaceutical Holdings Limited (China Resources Pharmaceutical Holdings), has completed the public issuance in China of the second tranche of its 2026 corporate bonds. The second tranche of the 2026 corporate bonds, with a principal amount of RMB 900 million, has been issued, with a term of three years and a coupon annual interest rate of 1.48%.